United States · FDA National Drug Code directory
Ultramicrosize Griseofulvin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42794-013_d58d8124-4925-b8a1-e053-2995a90ac4c5
- Product NDC
- 42794-013
- Form
- TABLET
- Composition / generic term
- Ultramicrosize Griseofulvin
- Labeler
- Sigmapharm Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20121115
- Source listing expiry
- 20261231
Source-listed ingredients
- GRISEOFULVIN — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (42794-013-08) · 42794-013-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →